Skip to main content


Hydroxychloroquine, antimalarial drug touted by President Trump, is linked to increased risk of death in coronavirus patients, study says

By The Washington Post  
   May 22, 2020

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.

Full story

Get the latest on healthcare leadership in your inbox.